Impact of the Food and Drug Administration's antipsychotic black box warning on psychotropic drug prescribing in elderly patients with dementia in outpatient and office-based settings.

Impact of the Food and Drug Administration's antipsychotic black box warning on psychotropic drug prescribing in elderly patients with dementia in outpatient and office-based settings.

Item
http://www.wikidata.org/entity/Q53675410
Caregiver and care recipient characteristics as predictors of psychotropic medication use in community-dwelling dementia patients.Perceptions vs. evidence: therapeutic substitutes for antipsychotics in patients with dementia in long-term care.Trends in use of antipsychotics in elderly patients with dementia: Impact of national safety warningsTrends in treatment with antipsychotic medication in relation to national directives, in people with dementia - a review of the Swedish contextAssociation between pain, neuropsychiatric symptoms, and physical function in dementia: a systematic review and meta-analysis.How much to worry about the FDA warning in the use of citalopram?Antipsychotic prescription amongst hospitalized patients with dementia.Pharmaceutical Benefit-Risk Communication Tools: A Review of the Literature.Time trends in antipsychotic drug use in patients with dementia: a nationwide study.Treated Behavioral Symptoms and Mortality in Medicare Beneficiaries in Nursing Homes with Alzheimer's Disease and Related Dementias.Persistence of racial disparities in prescription of first-generation antipsychotics in the USA.Antipsychotic Use in Dementia.Exposure to psychotropics in the French older population living with dementia: a nationwide population-based study.Evolution of the Antidepressant Prescribing in Alzheimer's Disease and Related Disorders Between 2010 and 2014: Results from the French National Database on Alzheimer's Disease (BNA).Neuroleptic equivalent dose differences and behavioral and psychological symptoms of dementia.
P2860

Impact of the Food and Drug Administration's antipsychotic black box warning on psychotropic drug prescribing in elderly patients with dementia in outpatient and office-based settings.

Item
http://www.wikidata.org/entity/Q53675410
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Impact of the Food and Drug Ad ...... ent and office-based settings.
@en
Impact of the Food and Drug Ad ...... ent and office-based settings.
@nl
type
label
Impact of the Food and Drug Ad ...... ent and office-based settings.
@en
Impact of the Food and Drug Ad ...... ent and office-based settings.
@nl
prefLabel
Impact of the Food and Drug Ad ...... ent and office-based settings.
@en
Impact of the Food and Drug Ad ...... ent and office-based settings.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Impact of the Food and Drug Ad ...... ent and office-based settings.
@en
P2093
P304
P31
P356
10.1016/J.JALZ.2011.08.004
P433
P478
P577
P698